Raimon Sanmartí Selected Research

Palindromic rheumatism

12/2021	Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status.
1/2017	Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
3/2015	Anti-citrullinated peptide/protein antibodies in palindromic rheumatism: comment on the article by Emad Y et al.
10/2012	Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
8/2007	An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raimon Sanmartí Research Topics

Disease

56	Rheumatoid Arthritis 08/2022 - 03/2004
7	Psoriatic Arthritis 01/2021 - 05/2004
6	Arthritis (Polyarthritis) 01/2022 - 05/2004
5	Palindromic rheumatism 12/2021 - 08/2007
5	Inflammation (Inflammations) 07/2021 - 10/2010
5	Synovitis 12/2019 - 05/2004
5	Infections 03/2019 - 07/2013
5	Rheumatic Diseases (Rheumatism) 07/2015 - 10/2006
4	Ankylosing Spondylitis 01/2019 - 10/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 10/2011
2	Neoplasms (Cancer) 01/2017 - 12/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 09/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2013 - 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Abdominal Pain (Pain, Abdominal) 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Fever (Fevers) 12/2021
1	Pericarditis 12/2021
1	COVID-19 01/2021
1	Tenosynovitis 12/2019
1	Human Influenza (Influenza) 03/2019
1	Osteoporosis 03/2019
1	Axial Spondyloarthritis 01/2019
1	Vasculitis (Vasculitides) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Edema (Dropsy) 12/2017
1	Joint Diseases (Joint Disease) 08/2016
1	Acute-Phase Reaction 02/2016
1	Tertiary Lymphoid Structures 07/2015
1	Skin Diseases (Skin Disease) 12/2013
1	Localized Scleroderma (Morphea) 08/2012
1	Hyperpigmentation 08/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2012
1	Spondylarthritis (Spinal Arthritis) 10/2011
1	Hyperplasia 09/2011
1	Disease Progression 04/2011
1	Sarcoidosis (Schaumann Disease) 04/2011
1	Pulmonary Sarcoidosis 04/2011
1	Posterior Uveitis 10/2010
1	Pathologic Complete Response 10/2010
1	Amyloidosis 01/2009

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 12/2021 - 10/2006
14	AntibodiesIBA 12/2021 - 07/2007
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
9	Biological ProductsIBA 01/2022 - 01/2014
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2009
7	Infliximab (Remicade)FDA Link 01/2019 - 03/2004
6	Tumor Necrosis Factor InhibitorsIBA 06/2022 - 04/2011
6	AutoantibodiesIBA 05/2022 - 10/2006
6	tocilizumab (atlizumab)FDA Link 10/2020 - 01/2015
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2004
5	Antirheumatic Agents (DMARD)IBA 01/2021 - 12/2011
5	acetyl 4-aminosalicylic acidIBA 01/2019 - 04/2011
5	CytokinesIBA 01/2017 - 04/2012
4	Etanercept (Enbrel)FDA Link 01/2019 - 03/2004
4	Rituximab (Mabthera)FDA Link 01/2018 - 01/2011
4	FibrinIBA 01/2018 - 10/2006
3	Abatacept (Orencia)FDA Link 08/2022 - 05/2010
3	Monoclonal AntibodiesIBA 10/2020 - 03/2007
3	Pharmaceutical PreparationsIBA 09/2020 - 01/2017
3	Adalimumab (Humira)FDA Link 01/2019 - 04/2011
3	Anti-Citrullinated Protein AntibodiesIBA 07/2012 - 08/2007
2	GlucocorticoidsIBA 05/2020 - 01/2014
2	C-Reactive ProteinIBA 12/2019 - 01/2018
2	golimumab FDA Link 01/2019 - 05/2015
2	Filaggrin ProteinsIBA 01/2018 - 01/2009
2	EpitopesIBA 01/2017 - 10/2006
2	Leflunomide (Arava)FDA LinkGeneric 01/2015 - 12/2011
1	Colchicine FDA LinkGeneric 12/2021
1	Rheumatoid FactorIBA 12/2021
1	Certolizumab Pegol FDA Link 09/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	N-phthaloylglutamic acidIBA 12/2019
1	Indicators and Reagents (Reagents)IBA 05/2019
1	Vitamin D FDA LinkGeneric 03/2019
1	GlycosaminoglycansIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2017
1	Interleukin-23 (Interleukin 23)IBA 07/2015
1	Interleukin-23 Subunit p19IBA 07/2015
1	LigandsIBA 07/2015
1	Interleukin-17 (Interleukin 17)IBA 07/2015
1	CXC ChemokinesIBA 07/2015
1	CC ChemokinesIBA 07/2015
1	Angiopoietin-2IBA 01/2014
1	Vascular Endothelial Growth Factor DIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2014
1	cyclo(Arg-Pro) (CI 4)IBA 12/2013
1	Immunoglobulin G (IgG)IBA 07/2013
1	VimentinIBA 11/2011
1	Carbon Nanotubes (Carbon Nanotube)IBA 09/2011
1	difluprednate FDA Link 04/2011

Therapy/Procedure

19	Therapeutics 06/2022 - 05/2004
9	Biological Therapy 06/2018 - 12/2013
3	Drug Tapering 10/2020 - 01/2014
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Remission Induction 02/2016
1	Telescopes 10/2010